(Q35126393)

English

Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bernhard Walder

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jacques-André Romand

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Miriam M. Treggiari

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744357

1 January 2024

Peter M. Suter

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744357

1 January 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744357

1 January 2024

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

full work available at URL

https://thejns.org/view/journals/j-neurosurg/98/5/article-p978.xml

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

https://thejns.org/downloadpdf/journals/j-neurosurg/98/5/article-p978.xml

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Journal of Neurosurgery

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

978-984

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Management of aneurysmal subarachnoid hemorrhage

2

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Meta-analysis in clinical trials

3

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage

4

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Cerebral arterial spasm--a clinical review

5

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Observations on the perioperative management of aneurysmal subarachnoid hemorrhage

8

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Therapeutic management of grade IV aneurysm patients

9

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Hyperdynamic therapy for cerebral vasospasm.

10

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Surgical risk as related to time of intervention in the repair of intracranial aneurysms

11

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

12

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Postoperative hypertension in the management of patients with intracranial arterial aneurysms

13

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial

14

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Cardiac performance indices during hypervolemic therapy for cerebral vasospasm

15

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm.

16

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Prophylactic Hypervolemia without Calcium Channel Blockers in Early Aneurysm Surgery

17

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.

18

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

19

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

20

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow.

22

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage

23

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Randomized trials or observational tribulations?

25

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report

28

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Complications of Swan-Ganz catheterization for hemodynamic monitoring in patients with subarachnoid hemorrhage

29

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

30

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm.

31

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study

32

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery. Results of a preliminary trial

33

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage

35

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy

36

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Beta blockade during and after myocardial infarction: an overview of the randomized trials

37

1 reference

10.3171/JNS.2003.98.5.0978

https://api.crossref.org/works/10.3171/JNS.2003.98.5.0978

1 January 2024

Identifiers

10.3171/JNS.2003.98.5.0978

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35126393&oldid=2104971446"